NGF-Induced Nav1.7 Upregulation Contributes to Chronic Post-surgical Pain by Activating SGK1-Dependent Nedd4-2 Phosphorylation

Mol Neurobiol. 2021 Mar;58(3):964-982. doi: 10.1007/s12035-020-02156-1. Epub 2020 Oct 16.

Abstract

At present, chronic post-surgical pain (CPSP) is difficult to prevent and cure clinically because of our lack of understanding of its mechanisms. Surgical injury induces the upregulation of voltage-gated sodium channel Nav1.7 in dorsal root ganglion (DRG) neurons, suggesting that Nav1.7 is involved in the development of CPSP. However, the mechanism leading to persistent dysregulation of Nav1.7 is largely unknown. Given that nerve growth factor (NGF) induces a long-term increase in the neuronal hyperexcitability after injury, we hypothesized that NGF might cause the long-term dysregulation of Nav1.7. In this study, we aimed to investigate whether Nav1.7 regulation by NGF is involved in CPSP and thus contributes to the specific mechanisms involved in the development of CPSP. Using conditional nociceptor-specific Nav1.7 knockout mice, we confirmed the involvement of Nav1.7 in NGF-induced pain and identified its role in the maintenance of pain behavior during long-term observations (up to 14 days). Using western blot analyses and immunostaining, we showed that NGF could trigger the upregulation of Nav1.7 expression and thus support the development of CPSP in rats. Using pharmacological approaches, we showed that the increase of Nav1.7 might be partly regulated by an NGF/TrkA-SGK1-Nedd4-2-mediated pathway. Furthermore, reversing the upregulation of Nav1.7 in DRG could alleviate spinal sensitization. Our results suggest that the maintained upregulation of Nav1.7 triggered by NGF contributes to the development of CPSP. Attenuating the dysregulation of Nav1.7 in peripheral nociceptors may be a strategy to prevent the transition from acute post-surgical pain to CPSP.

Keywords: Chronic post-surgical pain; NGF; Nav1.7; SGK1; p-Nedd4-2.

MeSH terms

  • Analgesics / pharmacology
  • Animals
  • Behavior, Animal / drug effects
  • Benzamides / pharmacology
  • Brain-Derived Neurotrophic Factor / metabolism
  • Ganglia, Spinal / drug effects
  • Ganglia, Spinal / metabolism
  • Hydrazines / pharmacology
  • Immediate-Early Proteins / antagonists & inhibitors
  • Immediate-Early Proteins / metabolism*
  • Indoles / pharmacology
  • Male
  • Mice
  • Mice, Knockout
  • Models, Biological
  • NAV1.7 Voltage-Gated Sodium Channel / genetics*
  • NAV1.7 Voltage-Gated Sodium Channel / metabolism
  • Nedd4 Ubiquitin Protein Ligases / metabolism*
  • Nerve Growth Factor / pharmacology*
  • Pain, Postoperative / genetics*
  • Pain, Postoperative / pathology
  • Phosphorylation / drug effects
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / metabolism*
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, trkA / antagonists & inhibitors
  • Receptor, trkA / metabolism
  • Spinal Cord / pathology
  • Ubiquitination / drug effects
  • Up-Regulation* / drug effects
  • Vesicular Glutamate Transport Protein 2 / metabolism

Substances

  • Analgesics
  • Benzamides
  • Brain-Derived Neurotrophic Factor
  • EMD 638683
  • GW 441756
  • Hydrazines
  • Immediate-Early Proteins
  • Indoles
  • NAV1.7 Voltage-Gated Sodium Channel
  • Vesicular Glutamate Transport Protein 2
  • Nerve Growth Factor
  • NEDD4L protein, rat
  • Nedd4 Ubiquitin Protein Ligases
  • Receptor, trkA
  • Protein Serine-Threonine Kinases
  • serum-glucocorticoid regulated kinase